Human Papilloma Virus Vaccine

Known as: HPV vaccine, Recombinant Human Papilloma Virus Vaccine, Human Papillomavirus Vaccines 
A vaccine used to prevent genital warts, cervical cancer, vulvar cancer, and vaginal cancer caused by certain types of human papillomavirus (HPV). It… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1969-2017
010020019692017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
OBJECTIVE To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVE To assess human papillomavirus (HPV) vaccination coverage after demonstration projects conducted in India, Peru, Uganda… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Quadrivalent human papillomavirus (HPV) vaccine has high efficacy in clinical trials but no reports describe its… (More)
  • table 1
  • figure 2
  • table 2
Is this relevant?
2011
2011
OBJECTIVES (1) Describe content and character of patient-physician human papilloma virus (HPV) vaccine discussions; (2) explore… (More)
Is this relevant?
2011
2011
Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection with an estimated worldwide… (More)
  • table 1
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND The cost-effectiveness of prophylactic vaccination against human papillomavirus types 16 (HPV-16) and 18 (HPV-18) is… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
 
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will require a high level of sustained… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND The ongoing development of a vaccine against human papillomavirus (HPV) raises important questions about the impact of… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?